Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurogene (NGNE) Other Non-Current Liabilities (2018 - 2025)

Neurogene (NGNE) has disclosed Other Non-Current Liabilities for 4 consecutive years, with $427000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Other Non-Current Liabilities rose 737.25% year-over-year to $427000.0, compared with a TTM value of $427000.0 through Sep 2025, up 737.25%, and an annual FY2024 reading of $718000.0, changed N/A over the prior year.
  • Other Non-Current Liabilities was $427000.0 for Q3 2025 at Neurogene, down from $738000.0 in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $738000.0 in Q1 2025 and bottomed at $51000.0 in Q2 2024.